Richard C. Young & Co’s AbbVie ABBV Stock Holding History

Richard C. Young & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.01M	Buy	35,810 +1,237	+4%	+$266K	0.66%	49
2026 Q1	$7.52M	Buy	34,573 +1,180	+4%	+$262K	0.62%	51
2025 Q4	$7.4M	Buy	33,393 +6,966	+26%	+$1.59M	0.66%	51
2025 Q3	$6.12M	Buy	26,427 +689	+3%	+$140K	0.57%	56
2025 Q2	$4.78M	Buy	25,738 +605	+2%	+$112K	0.47%	60
2025 Q1	$5.27M	Sell	25,133 -4	-0%	-$778	0.57%	59
2024 Q4	$4.47M	Buy	25,137 +2,014	+9%	+$370K	0.49%	61
2024 Q3	$4.57M	Buy	23,123 +3,653	+19%	+$682K	0.5%	56
2024 Q2	$3.34M	Buy	19,470 +5,580	+40%	+$924K	0.41%	55
2024 Q1	$2.53M	Buy	+13,890	New	+$2.39M	0.32%	58

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Richard C. Young & Co's ABBV Position: Q2 2026 in Review

Richard C. Young & Co increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $266K and bringing the position to 35,810 shares worth $9.01M. The position accounts for 0.66% of the portfolio, ranked #49.

Richard C. Young & Co first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 1,771 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Richard C. Young & Co held 35,810 shares of AbbVie worth $9.01M as of Q2 2026.
Richard C. Young & Co bought 1,237 AbbVie shares in Q2 2026, an estimated $266K.
AbbVie made up 0.66% of Richard C. Young & Co's portfolio in Q2 2026, its #49 holding.
Richard C. Young & Co first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
1,771 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Richard C. Young & Co's 13F filing for Q2 2026, filed 28 Jul 2026.